七氟烷麻醉下阿芬太尼标准剂量后瞳孔疼痛指数变化:新型瞳孔测量指数首次评估
BACKGROUND: The pupillary pain index (PPI) is a novel pupillometric index, designed to assess intraoperative analgesia. It is based on the evaluation of the pupillary response to electrical stimuli of increasing intensity.…
要点
- 阿芬太尼10 µg·kg(-1)后PPI中位数由6降至2,中位差值-3(95%CI -4至-2)。
核心结论
- 阿芬太尼给药后PPI显著降低,提示镇痛水平升高时PPI评分下降。
- PPI测量未伴随临床或血流动力学伤害性反应,可能有助于在全麻伤害性刺激前个体化调整阿片类药物。
研究设计与样本
- 前瞻性、开放标签、注册的试点研究(NCT02646592),纳入20名健康儿童(9±5岁)择期全麻手术。
- 麻醉诱导标准化为七氟烷6%和丙泊酚1 mg·kg(-1),气管插管后七氟烷浓度维持2%共10分钟。
- 首次PPI测量后给予阿芬太尼10 µg·kg(-1),2分钟后行第二次PPI测量。
- PPI评分前后比较采用Wilcoxon符号秩检验。
主要发现
- PPI评分在阿芬太尼后下降,中位差值为-3(95%CI -4至-2)。
- PPI测量期间未发生体动反应。
临床怎么用
- PPI评分从1(低瞳孔反应性,高镇痛水平)到10(高瞳孔反应性,低镇痛水平),可用于评估术中镇痛水平。
- 在七氟烷全麻下,PPI降低提示阿芬太尼镇痛效应,可考虑用于伤害性刺激前个体化调整阿片类药物。
局限性
- 试点研究样本量小(20名儿童),需进一步验证。
- 研究为开放标签设计,未设盲。
- 仅评估单次阿芬太尼剂量后的短期PPI变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The pupillary pain index (PPI) is a novel pupillometric index, designed to assess intraoperative analgesia. It is based on the evaluation of the pupillary response to electrical stimuli of increasing intensity. It ranges from 1 (low level of pupillary reactivity, high level of analgesia) to 10 (high level of pupillary reactivity, low level of analgesia). In this first evaluation of the PPI, our objective was to investigate the PPI changes after a bolus of 10 µg·kg(-1) of alfentanil in children under sevoflurane general anesthesia. METHODS: After ethics committee approval and informed consent, 20 healthy children (9 ± 5 years) undergoing elective surgery under general anesthesia were included in this prospective, open, registered pilot study (NCT02646592). Anesthetic induction was standardized with sevoflurane 6% and propofol 1 mg·kg(-1). After tracheal intubation, sevoflurane concentration was maintained at 2% for 10 minutes. A first PPI measurement was performed (PPI-1), and a bolus of 10 µg·kg(-1) was administered. Two minutes after this bolus, a second PPI measurement was performed (PPI-2). Heart rate, blood pressure, and bispectral index were recorded before and after each PPI measurement. Resting pupillary diameter was recorded before each PPI measurement. PPI scores before and after the bolus of alfentanil were compared using a Wilcoxon signed rank test. RESULTS: PPI scores decreased after administration of a bolus of alfentanil (median difference: -3 [95% confidence interval, -4 to -2]). The median (quartiles) of PPI-1 (baseline, before alfentanil) was 6 (4, 7), and the median (quartiles) of PPI-2 (after alfentanil) was 2 (2, 3) (P < .001). No difference was found in resting pupillary diameter before PPI-1 and PPI-2 (2.2 ± 0.2 and 2.2 ± 0.3 mm, respectively; P = .86). There were no significant changes in heart rate or blood pressure after PPI measurements (P = .46 and .49, respectively). Bispectral index was slightly increased after PPI measurements (P = .01; mean bispectral index increase <5%). No withdrawal movements occurred during PPI measurements. CONCLUSIONS: There was a significant decrease in PPI after alfentanil administration. The results of this pilot study suggest that PPI score decreases when the level of analgesia increases. PPI measurement was not associated with a clinical or hemodynamic nociceptive response. This new index might provide useful information to individually adapt opioid administration before nociceptive stimuli under general anesthesia.
引用
- Sabourdin N, Diarra C, Wolk R, et al. Pupillary Pain Index Changes After a Standardized Bolus of Alfentanil Under Sevoflurane Anesthesia: First Evaluation of a New Pupillometric Index to Assess the Level of Analgesia During General Anesthesia. Anesth Analg. 2019. PMID: 30198934. doi:10.1213/ANE.0000000000003681
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。